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Objectives. We tested the hypothesis that psychological stress 
alters plasma levels of opioid peptides and that these plasma 
levels are related to pain perception in patients with coronary 
artery disease. 
Background. Public speaking psychological stress has previ- 
ously been shown to be associated with silent ischemia. 
Methods. After instrumentation and a 30-min rest period, 
venous blood samples for beta-endorphin were obtained before 
and immediately after psychological stress in 20 patients with 
coronary artery disease. Pain threshold was then assessed using a 
thermal probe technique at baseline and immediately after stress. 
Patients gave three brief speeches lasting a total of 15 min about 
real-life hassle situations. 
Results. Psychological stress significantly increases plasma 
beta-endorphin levels (4.3 +- 0.9 pmol/liter [mean + SE] at rest to 
8.3 -+ 2 pmol/liter after stress, p < 0.05). There was a significant 
positive correlation between pain threshold and beta-endorphin 
levels after stress (r = 0.577, p = 0.008). This significant positive 
correlation was still present while rest blood pressure and change 
in blood pressure during stress were controlled for by analysis of 
covariance techniques. 
Conclusions. In patients with coronary artery disease and 
exercise-induced ischemia, public speaking produces psychologi- 
cal stress manifested by increased cardiovascular eactivity and 
causes an increase in plasma beta-endorphin levels that is signif- 
icantly correlated with pain thresholds. These findings may 
explain the predominance of silent ischemia during psychological 
stress in patients with coronary artery disease. 
(J Am Coll Cardiol 1995;25:1499-503) 
We previously reported (1) a comparison of beta-endorphin 
levels in patients with coronary artery disease and exercise- 
induced ischemia both at rest and after stress and found 
differences in the stress response between patients with silent 
and symptomatic ischemia nd differences between psycholog- 
ical and exercise stress. We further hypothesized that psycho- 
logical stress-induced ischemia may be more frequently silent 
because it is associated with a greater increase in plasma 
beta-endorphin per unit of change in double product (1). 
However, our previous work was performed without simulta- 
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neously measured pain thresholds. Because of the controversy 
about he relation between peripheral plasma beta-endorphin 
levels and pain perception, we undertook the present study to 
further examine the hypothesis previously reported and to 
examine the relation between circulating beta-endorphin levels 
both at rest and after stress and objective measurements of 
pain perception utilizing a thermal psychophysical procedure. 
Methods  
Patients participating in the study were recruited from the 
inpatient and outpatient cardiology services of University of 
North Carolina Hospitals as well as local outpatient cardiac 
rehabilitation programs. The protocol was approved by the 
Committee on the Protection of the Rights of Human Subjects 
at the University of North Carolina, and written informed 
consent was obtained for each subject. Twenty patients (mean 
[_+SE] age 60 +_ 2 years, range 47 to 78) with coronary artery 
disease and positive xercise test results were studied. Criteria 
for coronary artery disease were at least one of the following: 
1) arteriographically proved diameter narrowing <70% in at 
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Figure 1. Psychological stress ession protocol. BP = blood pressure; 
ECG = electrocardiogram; prep = preparation. 
least one major coronary artery; 2) previous myocardial infarc- 
tion documented by at least two of the following criteria-- 
typical pain, evolutionary electrocardiographic (ECG) changes 
or significant elevations of creatine kinase-MB fraction in 
serum (more than two times normal); 3) typical angina and 
positive xercise test results (->1 mm horizontal or downslop- 
ing ST segment depression at 0.08 s after the J point) with a 
>90% posttest likelihood of disease based on Diamond and 
Forrester (2) criteria; 4) positive radionuclide study (failure to 
increase left ventricular ejection fraction ->5% and develop- 
ment of segmental wall motion abnormalities on blood pool 
scan or reversible perfusion defects on thallium scan). 
Pain assessment/pain threshold and tolerance. Thermal 
pain threshold and pain tolerance were determined by utilizing 
a thermal probe technique (3). Thermal stimuli ranging from 
40 to 50°C were delivered to the volar forearm with a contact 
thermode. Each temperature was delivered for 5 s in an 
ascending series and 0.5°C increments. The delivery of stimuli 
was under computer control. Patients reported when they first 
considered the stimulus to be painful (threshold) and when the 
stimulus reached their pain tolerance l vel (tolerance). Three 
ascending series of temperatures were presented to different 
areas of the volar forearm. Average threshold and tolerance 
levels were then determined. This thermal probe technique has 
been shown to be an appropriate noxious timulus for testing 
purposes (4). Thermal stimuli provide a quantified stimulus 
that can be varied between threshold and tolerance, stimulate 
a restricted group of nociceptors in the pain sensitivity range 
and provide a quality of stimulus that is constant across pain 
sensitivity range in humans (4). To assess reproducibility in
baseline control measurements, baseline pain threshold and 
tolerance were determined on two separate days at the same 
time of day. 
Psychological stress protocol. A 12-lead ECG was re- 
corded immediately before, each minute during and for at least 
8 min after stress. Leads II, V 4 and V 5 were continuously 
monitored. An ambulatory ECG was placed during the rest 
period and timer synchronized sothat accurate analysis could 
be subsequently performed. Leads V5 and II were monitored. 
The event recorder was pressed at specific times in the 
protocol so that ECG data could be carefully compared with 
other data obtained. Significant ischemia on the ECG was 
defined as 1 mm horizontal or downsloping ST segment 
depression at 0.08 s after the J point. Figure 1 shows the time 
line for the experimental session. The psychological stress test 
consisted of continuous preparation for and presentation of
three brief tape-recorded speeches involving a real-life hassle 
situation (the unwanted house guest; a relative being mis- 
treated in a nursing home; and dealing with a store that will not 
honor an advertised special). A brief description of each of the 
three topics was read to him or her. The patient was then 
allowed 2 min to prepare and 3 min to deliver the speech into 
the microphone of a tape recorder. Two minutes of prepara- 
tion time for the second speech then commenced, and the 
same sequence was repeated with no pauses to permit recov- 
ery, so that the 5-rain preparation/speaking period repeated 
three times constituted a 15-min stress-inducing task. An 
audience of three people (two familiar and one stranger, 
including members of both genders) was present and main- 
tained eye contact with the speaker throughout. To reduce 
habituation, just before the second speech, the assistant in- 
formed the speaker that he or she would receive a small cash 
bonus ($5) if the second speech was rated equal to or better 
than the first by the audience. The same instruction with a 
bonus of $10 was given before the third speech. Blood pressure 
and heart rate were monitored at 1-min intervals by an 
automated manometric blood pressure cuff (Accutor). At 
completion of the task the patient was asked whether chest 
pain occurred uring the preparation period or the speech, and 
this was recorded as a dichotomous outcome. Pain testing was 
repeated immediately after stress (within 5 min). 
Beta-endorphin measurement. After instrumentation a d 
a 30-min rest period, venous blood samples for beta-endorphin 
measurement were obtained immediately before and immedi- 
ately after stress testing. Specimens were collected into tubes 
containing ethylenediaminetetraacetic acid (EDTA). After 
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Table 1. Clinical and Angiographic Data 
Diseased 
History of History of Myocardial Vessels on History of 
Angina Infarction Catheterization Hypertension Medications 
Y - 16 (80%) Y : 5 (25%) l vessel : 8 Y : 12 (60%) BB : 9 (45%) 
N = 4 (2f1%) N = 15 (75%) 2vessel = 2 N - 8 (40%) CA = 10 (50%) 
3 vessel = 2 LA = 12 (60%) 
Data presented are number (%) of patients. BB = beta-adrenergic blo king agent; CA - calcium channel b ocking 
agent; LA = long-acting itrate; N = no; Y = yes. 
centrifugation, the plasma was aspirated and immediately 
frozen at -70°C until assayed. All samples were assayed in 
duplicate for beta-endorphin concentration using a radioim- 
munoassay kit (INCSTAR Corporation). The recovery ield 
from plasma determined using internal standards ranged be- 
tween 80% and 106%. The antibody cross-reacts 100% with 
human beta-endorphin, shows <5% cross-reactivity with beta- 
lipotropin and has no cross-reactivity with related peptides and 
hormones, such as alpha-endorphin, gamma-endorphin, 
leucine enkephalin, methionine nkephalin or adrenoeortico- 
trophic hormone (ACTH). The sensitivity of the assay, defined 
as the apparent concentration at three standard deviations 
from counts at maximal binding, is <3 pmol/liter. The intra- 
assay and interassay coefficients of variation were 5.76% and 
17.1%, respectively. 
Statistical methods. Descriptive statistics are expressed as 
mean value + SE throughout he text and in the tables. 
Significant changes in hemodynamic and beta-endorphin val- 
ues from before to after stress or rest to peak stress were 
assessed with paired t tests and Wilcoxon signed rank tests. 
Pearson correlations were used to assess the relation between 
pain threshold and beta-endorphin levels and with the square 
root of beta-endorphin levels to address the relative influence 
of large values. Evaluation of the relation to the square root of 
beta-endorphin levels with adjustment for rest blood pressure 
and change in blood pressure during stress was accomplished 
with adjusted slopes from multiple linear regression analyses. 
Resu l ts  
Clinical and hemodynamic data. Table 1 shows clinical and 
angiographic data: 16 patients (80%) had a history of stable 
angina pectoris, and 9 (45%) had experienced an anginal 
episode within 3 weeks before the study. Five patients (25%) 
had experienced myocardial infarction ->3 weeks before the 
study. Twelve patients (60%) had undergone cardiac catheter- 
ization, which revealed three-vessel disease in two (16%), 
two-vessel disease in two (16%) and one-vessel disease in eight 
(67%). Twelve patients (60%) were diagnosed with or being 
treated for hypertension. 
No patient had valvular heart disease or major systemic 
illness, uncontrolled hypertension, orthopedic or peripheral 
vascular disease precluding bicycle exercise or was pregnant. 
Patients were excluded for conditions known or suspected to 
influence pain perception (diabetes mellitus, alcohol abuse, 
previous coronary surgery) or to decrease the specificity of 
exercise-induced ST segment depression (digitalis prepara- 
tions, left bundle branch block or left ventricular hypertrophy 
on baseline ECG). Eighteen of 20 patients were studied while 
taking cardiac medications (beta-adrenergic blocking agents, 
calcium antagonists, long-acting nitrates). Previous work (1) 
has shown no effect of these medications on beta-endorphin 
levels or responses to stress. 
Table 2 shows hemodynamic data. During the psychological 
stress protocol, systolic blood pressure increased from 138 _+ 
4.01 mm Hg at rest to 180 _+ 4.01 mm Hg at peak stress, and 
heart rate increased from 65 _+ 2.93 beats/min at rest to 78 _+ 
3.59 beats/rain at peak stress. These values corresponded to a 
mean rest rate-pressure product of 9,047 _+ 508 and a mean 
peak product of 14,240 _+ 844. No patient had chest pain 
during psychological stress. Ten of 20 patients had evidence of 
stress-induced ischemia on the basis of ECG or radionuclide 
criteria. 
Beta-endorphin and pain threshold results. Table 3 sum- 
marizes the beta-endorphin and pain threshold results. Mean 
baseline plasma beta-endorphin level was 4.30 _+ 0.90 pmol/ 
liter, which increased to 8.33 _+ 2.11 pmol/liter immediately 
after stress. This mean absolute change (4.03 - 1.89 pmol/ 
liter) was significant at p = 0.012. This result represents a
clinically significant difference of the magnitude that one 
would be able to detect with a clinical dose of morphine (5). 
There was no significant difference in baseline pain thresh- 
Table 2. Hemodynamic Data Obtained During Psychological Stress Testing 
Peak 
Baseline Peak Stress Stress - Baseline 
Systolic blood pressure (mm Hg) 138 _+ 4.01 180 _+ 4.01 42 _+ 3.97 
Heart rate (beats/min) 65 _+ 2.93 78 -+ 3.59 13 _+ 2.20 
Rate-pressure product 9,047 _+ 508 14,240 _+ 844 5,193 _+ 611 
Data presented are mean value - SE. 
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Table 3. Pain Threshold and Beta-Endorphin Results 
After 
Baseline After Stress Stress - Baseline p Value 
Pain threshold (°C) 45.0 _+ 0.49 45.4 +_ 0.46 0.4 _+ 0.3 NS 
Beta-endorphin 4.30 _+ 0.90 8.33 _+ 2.i1 4.03 _+ 1.89 0.012 (WS) 
(pmol/liter) 
Data presented are mean value _+ SE. WS = Wilcoxon signed rank test. 
old determined on two separate days (p = 0.299). Baseline 
pain threshold was 45.0°C, which increased slightly but not 
significantly after stress (p = 0.18). There was no significant 
correlation between baseline pain threshold and beta- 
endorphin levels (r = 0.163, p = 0.492). There was a significant 
positive correlation between pain threshold and plasma beta- 
endorphin levels after psychological stress (r = 0.577, p = 
0.008). Because threshold was normally distributed and endor- 
phin values were skewed, we also correlated threshold with 
square roots of endorphin levels (r = 0.460, p = 0.041 for 
square roots, slope 0.668 _+ 0.304 SE). This significant positive 
relation was still present in multiple linear egression analyses 
controlling for rest blood pressure (slope 0.689 _+ 0.308 SE, 
p = 0.04) and change in blood pressure during stress (slope 
0.667 +_ 0.306 SE, p = 0.04). 
Discuss ion  
Significance of plasma opioid levels. There is considerable 
controversy in published reports regarding the significance of 
peripheral plasma levels of opioid peptides in mediating 
changes in pain perception and in the significance of cutaneous 
pain thresholds as adequate indicators of the status of visceral 
nociception, particularly as it relates to patients with cardiac 
ischemia. 
Several investigators (6-8) have reported that plasma 
opioid peptide levels positively correlate with pain perception 
indexes measured from cutaneous tissues. Others have not 
found such a relation (9,10). These reported ifferences may 
be due to many factors, including differences in patient popu- 
lations, such as possible gender differences to psychological 
stress (11), differences in assay techniques, differences in 
experimental protocol that might affect an adequate baseline 
status and differences in level of stress produced, which affect 
the degree of change in levels of opioid peptides and pain 
perception, and differences in the type of stressor applied 
(exercise vs. mental stress). In addition, not all types of 
pain-testing procedures are equivalent. For example, electrical 
pain testing is a nonspecific stimulus that activates many types 
of cutaneous receptors, whereas thermal pain testing more 
selectively stimulates neuronociceptive pathways (4). 
We previously showed differences between the plasma 
beta-endorphin response to exercise versus psychological stress 
(1) but did not measure pain thresholds. The present study 
confirms our previous work in that it shows significant in- 
creases in plasma beta-endorphin levels in response to a 
psychological stressor and in addition demonstrates that ther- 
mal pain thresholds after stress are significantly correlated with 
beta-endorphin levels (r = 0.58, p = 0.008). 
Some doubt he significance of peripheral levels of opioid 
peptides in adequately reflecting pain perception. The argu- 
ments given for this opinion are 1) the inconsistency in the 
reports previously cited; and 2) that beta-endorphin in the 
plasma does not cross the blood-brain barrier and therefore 
cannot be important in modifying nociception, because many 
believe that nociception is controlled entirely by central ner- 
vous system mechanisms. 
Circulating endorphin levels appear to influence pain per- 
ception and nociceptive r flexes (12), although this link has not 
been clearly established or its mechanism elucidated. It is 
thought that opiates may act peripherally by suppressing the 
release of algesic substances from primary afferents (13) or by 
stimulating specific opiate receptors on cardiopulmonary vagal 
afferents (14). A link between the cardiovascular baroreceptor 
reflex arc and pain regulatory systems in both animals and 
humans has been found (15,16), suggesting that in humans the 
clinical effect of baroreceptor stimulation may modify pain 
regulatory systems. However, the positive correlation between 
beta-endorphin levels and pain threshold after stress in the 
present study was still present while blood pressure change 
during stress was controlled. 
Baroreceptors and pain perception. A preliminary study by 
our group (17) suggests that stimulation of the baroreceptors 
may modify perception of myocardial ischemia pain in patients 
with coronary artery disease. Twenty-eight patients with coro- 
nary artery disease who had demonstrated angina nd positive 
exercise ECG findings underwent supine xercise radionuclide 
angiography. An index of ischemic pain perception was calcu- 
lated by determining time from the start of exercise to the 
onset of l-ram ST segment depression and subtracting that 
value from the time to the onset of angina. This index was 
positively correlated with systolic blood pressure at rest (p = 
0.03), and both the index and rest blood pressure correlated 
negatively with duration of angina (p < 0.01 and p < 0.001, 
respectively). 
Recently we showed that beta-endorphin plasma infusion 
modifies the nociceptive response to adenosine infusion (Syl- 
yen L, Sheps DS, unpublished observations). Adenosine is 
thought to be the major chemical mediator of ischemic ardiac 
pain, and therefore demonstration f an antinociceptive effect 
of intravenous beta-endorphin infusion in humans provides 
further proof that beta-endorphin exerts a physiologic effect in 
the peripheral venous blood. Another opioid peptide that is 
secreted peripherally in response to stress by the adrenal 
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medulla is met-enkephalin. We did not measure met- 
enkephalin i the present study, but it is also known to be an 
important opioid peptide involved in modulation of antinoci- 
ception. It has also bee n recently demonstrated to be present 
in cardiac myocytes and may play an important role in medi- 
ating localized physiological responses (18). 
Relevance of psychological stress. It must be emphasized 
that results obtained in the present study apply solely to a 
psychological stressor (public speaking) and cannot be as- 
sumed to be applicable to the situation that occurs with 
exercise stress. The hemodynamic and neuroendocrine r - 
sponses to exercise stress are different from those associated 
with psychological stress (lower epinephrine responses to 
exercise stress and more gradual blood pressure change), and 
therefore the relation described in the present study dealing 
with psychological stress may not be obtained with exercise. 
The importance and relevance of laboratory-evoked r sponses 
to psychological stress have been studied by Matthews et al. (19) 
who found that some cardiovascular reactors to a speech stressor 
in the laboratory had greater ambulatory systolic and diastolic 
blood pressure l vels during periods of stress (during ambulatory 
monitoring) than during periods of nonstress. These differences 
were more than four times those of the nonlaboratory eactors. 
Thus, the daily life implications ofa laboratory speech stressor are 
significant in at least some subjects. 
It has been shown that silent ischemia during daily life in 
patients with coronary artery disease is associated with an 
adverse prognosis. It is logical to postulate that patients who 
have greater blood pressure changes with psychological stress 
may also have more ambulatory silent ischemia, although to 
our knowledge this has not been tested. Thus, psychological 
stress-induced ischemia may also be associated with an adverse 
prognosis in patients with coronary artery disease. This hypoth- 
esis can be proved with a prospective study that follows up 
patients with ischemic heart disease after a psychological 
stressor. 
Summary. We showed that a public speaking psychological 
stressor produces increases in plasma beta-endorphin levels 
that are correlated with peripheral pain threshold in patients 
with coronary artery disease. This relation provides further 
support for an opioid mechanism for psychological stress- 
induced silent ischemia. The possible adverse clinical effect of 
such stressors occurring during daily life remains to be deter- 
mined. 
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